longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • CafΓ©
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Replimune

REPL

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
Share your thoughts

What's on your mind?

0 / 2,000
  • H
    Hardik ShahMay 29 at 11:37 AM

    πŸ“’ 𝐉𝐔𝐒𝐓 𝐈𝐍: $Replimune(REPL.US) Replimune To Resubmit Melanoma Treatment For Fda Approval - WSJ